Jenburkt Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: JENBURPH and BSE: 524731 (ISIN INE354A01013).
It has a market capitalisation of ₹406 crore, a last close of ₹920.95 on 2026-10-19.
Valuation: a price-to-earnings ratio of 11.70x, a price-to-book ratio of 2.06x, a dividend yield of 2.2%.
Profitability: return on equity of 18.8%, return on capital employed of 24.7%, an operating margin of 25.9%.
Growth: sales growth of 7.3% a year over three years, net profit growth of 12.2% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x.
| Metric | Value |
|---|---|
| Market capitalisation | 406 |
| Last close | ₹920.95 |
| P/E (TTM) | 11.70x |
| P/B | 2.06x |
| Dividend yield | 2.2% |
| ROE (FY) | 18.8% |
| ROCE (FY) | 24.7% |
| Operating margin (TTM) | 25.9% |
| Sales growth, 3-year CAGR | 7.3% |
| Profit growth, 3-year CAGR | 12.2% |
| Debt / equity | 0.00x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means